Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Meeker David P (CIK 1385155) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-14). Recent activity: Buy RYTM (50,000 shares), Sell RYTM (6,439 shares), Sell RYTM (30,746 shares), Sell RYTM (8,698 shares), Sell RYTM (1,817 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 50,000 | $302,500 |
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 6,439 | $655,145 |
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 30,746 | $3.1M |
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 8,698 | $899,634 |
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 1,817 | $189,965 |
| 2026-09-14 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 2,300 | $241,937 |
| 2026-06-22 | Kardigan, Inc. (KARD) | Director | Buy | 20,706 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 68,713 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 31,522 | $3.4M |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Buy | 43,620 | $200,216 |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 43,346 | $2.8M |
| 2025-06-05 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | President and CEO | Sell | 274 | $17,974 |
Source: SEC Form 4 filings · as of 2026-09-14